Last reviewed · How we verify

NCT07537452

Response of the Cardiac Autonomic Control System After Oxygen Therapy 100% in Hyperbaric Environment

Terminated Last updated 17 April 2026
What this trial tests

trial in Neurological Injury in 17 participants. Terminated before completion.

Timeline
1 August 2018
Primary endpoint
1 July 2020
1 July 2020

Quick facts

Lead sponsorAssaf-Harofeh Medical Center
StatusTerminated
Study typeOBSERVATIONAL
Enrollment17
Start date1 August 2018
Primary completion1 July 2020
Estimated completion1 July 2020
Sites1 location across Israel

Conditions studied

Sponsor

Assaf-Harofeh Medical Center

Who can join

Adults 18 to 80, any sex, with Neurological Injury. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to examine changes in cardiac autonomic nerve system function in patients receiving Hyperbaric oxygen therapy .

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Neurological Injury

Currently open trials in the same condition.

Other Assaf-Harofeh Medical Center trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07537452.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing